Antinociception produced by the peptidase inhibitor, RB 101, in rats with adrenal medullary transplant into the spinal cord

European Journal of Pharmacology

Volumn 356, Issue 2-3, 1998, Pages 139-148

  Ortega Alvaro, Antonio ^a,b   Chover Gonzalez, Antonio J ^a,b   Lai Kuen, René ^c   Mico, Juan A ^b   Gibert Rahola, Juan ^b   Fournié Zaluski, Marie Claude ^a   Roques, Bernard P ^a   Maldonado, Rafael ^a  

^a Laboratoire de Pharmacochimie   (France)

^b UNIVERSITY OF CÁDIZ   (Spain)

^c Lab d'Hyg et de S Publique   (France)

Author keywords

Adrenal medullary transplant; Antinociception; Enkephalin; Naloxone; Phentolamine; RB 101; Tail flick

Indexed keywords

ENKEPHALIN; N [3 [(2 AMINO 4 METHYLTHIO)BUTYLDITHIO] 2 BENZYLPROPIONYL]PHENYLALANINE BENZYL ESTER; NALOXONE; OPIATE RECEPTOR; PHENTOLAMINE;

ADRENAL MEDULLA; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTINOCICEPTION; ARTICLE; AUTOGRAFT; CONTROLLED STUDY; INTRAVENOUS DRUG ADMINISTRATION; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SPINAL CORD; SUBCUTANEOUS DRUG ADMINISTRATION; TAIL FLICK TEST; TISSUE TRANSPLANTATION;

EID: 0031787688     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00525-1     Document Type: Article

References (33)

1. Bourgoin, S., Le Bars, D., Artaud, F., Clot, A.M., Bouboutou, R., Fournié-Zaluski, M.C., Roques, B.P., Hamon, M., Cesselin, F., 1986. Effects of kelatorphan and other peptidase inhibitors on the in vitro and in vivo release of Met-enkephalin-like material from the rat spinal cord. J. Pharmacol. Exp. Ther. 238, 360-366.
2. D'Amour, F.E., Smith, D.L., 1941. A method to determine loss of pain sensation. J. Pharmacol. Exp. Ther. 72, 74-77.
3. Daugé, V., Mauborgne, A., Cesselin, F., Fournié-Zaluski, M.C., Roques, B.P., 1996. The dual peptidase inhibitor, RB 101, induces a long-lasting increase in the extracellular level of Met-enkephalin-like material in the nucleus accumbens of freely moving rats. J. Neurochem. 67, 1301-1308.
4. Eiden, L.E., Giraud, P., Dave, J.R., Hotchkiss, A.J., Affolter, H.U., 1984. Nicotinic receptor stimulation activates enkephalin release and biosynthesis in adrenal chromaffin cells. Nature 312, 661-663.
5. Fournié-Zaluski, M.C., Chaillet, P., Bouboutou, R., Coulaud, A., Chérot, P., Waksman, G., Costentin, J., Roques, B.P., 1984. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin-degrading enzymes. Eur. J. Pharmacol. 102, 525-528.
6. Fournié-Zaluski, M.C., Coric, P., Turcaud, S., Lucas, E., Noble, F., Maldonado, R., Roques, B.P., 1992. 'Mixed inhibitor prodrug' as a new approach towards systemically active inhibitors of enkephalin-degrading enzymes. J. Med. Chem. 35, 2473-2481.
7. Freed, W.J., Morihisa, J.M., Spoor, E., Hoffer, B.J., Olson, L., Seiger, A., Wyatt, R.J., 1981. Transplanted adrenal chromaffin cells in rat brain reduce lesion-induced rotational behavior. Nature 292, 351-352.
8. González-Darder, J.M., Ruz-Franzi, J.I., 1991. Accion antialgica del transplante de médula suprarrenal al espacio subaracnoideo lumbar. Estudio experimental. Rev. Esp. Anestesiol. Reanim. 38, 230-233.
9. Hama, A.T., Sagen, J., 1993. Reduced pain-related behavior by adrenal medullary transplants in rats with experimental painful peripheral neuropathy. Pain 52, 223-231.
10. IASP, 1983. Ethical standards for investigations of experimental pain in animals. Pain 16, 109-110.
11. Maldonado, R., Valverde, O., Turcaud, S., Fournié-Zaluski, M.C., Roques, B.P., 1994. Antinoceptive response induced by mixed inhibitors of the enkephalin catabolism in peripheral inflammation. Pain 58, 77-83.
12. NIH Publication No. 85-23, 1985. Guide for the care and use of laboratory animals. Rockville Pike, Bethesda.
13. Noble, F., Soleilhac, J.M., Soroca-Lucas, E., Turcaud, S., Fournié-Zaluski, M.C., Roques, B.P., 1992a. Inhibition of the enkephalin-metabolizing enzymes by the first systemically active mixed inhibitor prodrug, RB 101, induces potent analgesic responses in mice and rats. J. Pharmacol. Exp. Ther. 261, 181-190.
14. Noble, F., Turcaud, S., Fournié-Zaluski, M.C., Roques, B.P., 1992b. Repeated systemic administration of the mixed inhibitor of enkephalin-degrading enzymes, RB 101, did not induce either antinociceptive tolerance or cross-tolerance with morphine. Eur. J. Pharmacol. 223, 83-89.
15. Noble, F., Fournié-Zaluski, M.C., Roques, B.P., 1993. Unlike morphine, the endogenous enkephalins protected by RB 101 are unable to establish a conditioned place preference in mice. Eur. J. Pharmacol. 230, 139-149.
16. Noble, F., Coric, P., Turcaud, S., Fournié-Zaluski, M.C., Roques, B.P., 1994. Assessment of physical dependence after continuous perfusion in the rat jugular vein of the mixed inhibitor of enkephalin-degrading enzymes, RB 101. Eur. J. Pharmacol. 253, 283-287.
17. Ortega-Alvaro, A., Gibert-Rahola, J., Chover, A.J., Tejedor-Real, P., Casas, J., Mico, J.A., 1994. Effect of amitriptyline on the analgesia induced by adrenal medullary tissue transplanted in the rat spinal subarachnoid space as measured by an experimental model of acute pain. Exp. Neurol. 136, 1-6.
18. Ortega-Alvaro, A., Gibert-Rahola, J., Mellado-Fernández, M.L., Chover, A.J., Micó, J.A., 1997. The effects of different monoaminergic antide-pressants on the analgesia induced by spinal cord adrenal medullary transplants in the formalin test in rats. Anesth. Analg. 84, 816-820.
19. Pappas, G.D., Lazorthes, Y., Bes, J.C., Tafani, M., Winnie, A.P., 1997. Relief of intractable cancer pain by human chromaffin cell transplants: experience at two medical centers. Neurol. Res. 19, 71-77.
20. Perlow, M.J., 1987. Brain grafting as a treatment for Parkinson's disease. Neurosurgery 20, 335-342.
21. Reddy, S.V.R., Maderdrut, J.L., Yaksh, T.L., 1980. Spinal cord pharmacology of adrenergic agonists-mediated antinociception. J. Pharmacol. Exp. Ther. 213, 525-533.
22. Roques, B.P., Noble, F., Daugé, V., Fournié-Zaluski, M.C., Beaumont, A., 1993. Neutral endopeptidase 24.11: structure, inhibition and experimental and clinical pharmacology. Pharmacol. Rev. 45, 87-146.
23. Ruiz-Gayo, M., Baamonde, A., Turcaud, S., Fournié-Zaluski, M.C., Roques, B.P., 1992. In vivo occupation of mouse brain opioid receptors by endogenous enkephalins: blockade of enkephalin-degrading enzymes by RB 101 inhibits [3H] diprenorphine binding. Brain Res. 571, 306-312.
24. Ruz-Franzi, J.I., Gonzalez-Darder, J.M., 1991. Study of the analgesic effects of the implant of adrenal medullary into the subarachnoid space in rats. Acta Neurochir. 52 (Suppl.), 39-41.
25. Sagen, J., Kemmler, J.E., 1989. Increased levels of Met-enkephalin-like immunoreactivity in the spinal cord CSF of rats with adrenal medullary transplants. Brain Res. 502, 1-10.
26. Sagen, J., Wang, H., 1990. Prolonged analgesia by enkephalinase inhibition in rats with spinal cord adrenal medullary transplants. Eur. J. Pharmacol. 179, 427-433.
27. Sagen, J., Pappas, G.D., Perlow, M.J., 1986. Adrenal medullary tissue transplants in the rat spinal cord reduce pain sensitivity. Brain Res. 384, 189-194.
28. Sagen, J., Wang, H., Pappas, G.D., 1990. Adrenal medullary implants in rat spinal cord reduce nociception in a chronic pain model. Pain 42, 69-79.
29. Sagen, J., Kemmler, J.E., Wang, H., 1991. Adrenal medullary transplants increase spinal cord cerebrospinal fluid catecholamine levels and reduce pain sensitivity. J. Neurochem. 56, 623-627.
30. Valverde, O., Fournié-Zaluski, M.C., Roques, B.P., Maldonado, R., 1996. The CCK-B antagonist, PD-134,308 facilitates rewarding effects of endogenous enkephalins but does not induce place preference in rats. Psychopharmacology 123, 119-126.
31. Vaquero, J., Arias, A., Oya, S., Zurita, M., 1991. Chromaffin allografts into arachnoid of spinal cord reduce basal pain responses in rats. NeuroReport 2, 149-151.
32. Wang, H., Sagen, J., 1994. Absence of appreciable tolerance and morphine cross-tolerance in rats with adrenal medullary transplants in the spinal cord. Neuropharmacology 33, 681-692.
33. Winnie, A.P., Pappas, G.D., Das Gupta, T.K., Wang, H., Ortega, J.D., Sagen, J., 1993. Subarachnoid adrenal medullary transplants for terminal cancer pain. Anesthesiology 79, 644-653.